• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS US. CORP PRECISE PRO RX; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS US. CORP PRECISE PRO RX; STENT, CAROTID Back to Search Results
Catalog Number PC0830RXC
Device Problem Difficult to Remove (1528)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/22/2023
Event Type  malfunction  
Manufacturer Narrative
Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, after deployment of an 8mm x 30mm precise pro carotid self-expanding stent (ses), the precise pro delivery system would not come out of the patient¿s body.There were no reported injuries to the patient.An 8f infiniti guiding catheter was used during this procedure.The physician is experienced in the preparation and use of the device.The device will not be returned for evaluation.
 
Manufacturer Narrative
Complaint conclusion: as reported, after deployment of an 8mm x 30mm precise pro carotid self-expanding stent (ses), the precise pro delivery system would not come out of the patient¿s body.There were no reported injuries to the patient.An 8f infiniti guiding catheter was used during this procedure.The physician is experienced in the preparation and use of the device.Additional information was requested but was not provided.The device will not be returned for evaluation.The reported ¿stent delivery system (sds) withdrawal difficulty¿ could not be confirmed as the device was not returned for analysis.The exact cause cannot be determined.Based on the information provided and the limited procedural details given, it is likely procedural and/or handling factors contributed to the event reported.However, without the return of the device for analysis it is difficult to draw a clinical conclusion between the device and event reported.According to the instructions for use, which is not intended to mitigate risk, ¿initiate stent deployment by retracting the outer sheath while holding the inner shaft in a fixed position.Deployment is complete when the outer sheath marker passes the proximal inner shaft stent marker.Note: the mechanism for stent deployment is outer sheath retraction.Deployment is completed by maintaining inner shaft position while retracting the outer sheath and allowing the stent to expand (often referred to as the ¿pin-and-pull¿ method).Post-deployment stent dilatation: while using fluoroscopy, withdraw the entire delivery system as one unit, over the guidewire and out of the body.Remove the delivery device from the guidewire.Note: if any resistance is met during delivery system withdrawal, advance the outer sheath until the outer sheath marker contacts the catheter tip and withdraw the system as one unit.(do not remove guidewire.) using fluoroscopy, visualize the stent to verify full deployment.If incomplete expansion exists within the stent at any point along the lesion, post deployment balloon dilatation (standard pta technique) can be performed.¿ the information available does not suggests a design or manufacturing related cause for the reported event.Therefore, no corrective or preventive action will be taken at this time.
 
Event Description
As reported, after deployment of an 8mm x 30mm precise pro carotid self-expanding stent (ses), the precise pro delivery system would not come out of the patient¿s body.There were no reported injuries to the patient.An 8f infiniti guiding catheter was used during this procedure.The physician is experienced in the preparation and use of the device.Additional information was requested but was not provided.The device will not be returned for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISE PRO RX
Type of Device
STENT, CAROTID
Manufacturer (Section D)
CORDIS US. CORP
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
santiago troncoso 808
juarez, chihuahua 
7863138372
MDR Report Key18586764
MDR Text Key334834474
Report Number9616099-2024-00033
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/26/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Catalogue NumberPC0830RXC
Device Lot Number18237988
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received02/15/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/05/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
8F INFINITI GUIDE.
-
-